Roubaix Capital, LLC Maravai Lifesciences Holdings, Inc. Transaction History
Roubaix Capital, LLC
- $152 Million
- Q3 2024
A detailed history of Roubaix Capital, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Roubaix Capital, LLC holds 237,747 shares of MRVI stock, worth $1.69 Million. This represents 1.3% of its overall portfolio holdings.
Number of Shares
237,747
Previous 436,218
45.5%
Holding current value
$1.69 Million
Previous $3.12 Million
36.76%
% of portfolio
1.3%
Previous 2.25%
Shares
4 transactions
Others Institutions Holding MRVI
# of Institutions
223Shares Held
124MCall Options Held
176KPut Options Held
2.2K-
12 West Capital Management LP New York, NY13.2MShares$93.9 Million9.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$76.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$69.2 Million0.0% of portfolio
-
Braidwell LP Stamford, CT9.02MShares$64.2 Million2.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.97MShares$42.4 Million0.02% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $935M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...